MyAverix Finance
US · Healthcare
Genmab A/S (GNMSF)
Biotechnology
Genmab A/S (GNMSF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GNMSF
Genmab A/S (GNMSF) — FAQ
What is GNMSF's P/E ratio?
The price-to-earnings (P/E) ratio for Genmab A/S (GNMSF) is 25.00 (data as of 2026-05-23).
Does Genmab A/S pay a dividend?
Dividend yield is not available in the current snapshot for Genmab A/S (GNMSF). Check the MyAverix Finance app for the latest dividend data.
What sector is Genmab A/S in?
Genmab A/S (GNMSF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GNMSF listed on?
GNMSF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.